Market Tracker

06/23 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

85.21
Delayed Data
As of Jun 23
 +1.25 / +1.49%
Today’s Change
31.38
Today|||52-Week Range
86.92
+127.59%
Year-to-Date

Today’s Trading

Previous close83.96
Today’s open83.96
Day’s range82.13 - 85.33
Volume773,700
Average volume (3 months)1,046,411
Market cap$7.8B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-9.91%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book7.96

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-3.05-2.04%
RDYDr.Reddy's Laborator...+0.41+1.00%
IONSIonis Pharmaceutical...+0.25+0.46%
SGENSeattle Genetics Inc-1.51-2.39%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts